[rolph]

about 3/4 of theway thru the text i finally find some numbers

>>What has AstraZeneca said?

The company says there is no evidence of an increased risk of clotting due to the vaccine.

It said it had received 37 reports of blood clots out of more than 17 million people vaccinated in the EU and UK as of 8 March.<<

37 reports out of 17 million vaccinations.

this is aprox. 1 report out of 510 000 vaccinations.

what is not shown is spatial distribution over population. this would provide insight regarding statistical groups such as those who recieved a bad batch [if extant] or those with existing cerebovascular pathology concurrent with vaccination.

i cant say im a fan of the adenovirus vector approach, for technical reasons, however it does appear to be a vaccine for those not immune to adenovirus.

[hef19898]

According to some interviews and sources, the Sinus blood clots are more likely to happen with AZ. I haven't seen any numbers, especially accounting for age and demographic groups, so I cannot tell.

That being said, every drug has side effects. A vaccine isn't any different.

[rolph]

i would like the opportunity to read these "some interviews and sources" do you have any citations to append to your qualitative comment?

[hef19898]

One from the vaccine and immunology head of the Charité in Berlin. No idea where I read the other one, but it was in German as well. The Charité one is here:

https://www.spiegel.de/wissenschaft/medizin/astrazeneca-das-...